PROGNOSING BACTERIAL INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

Authors

  • I. O. Stoma
  • I. A. Karpov
  • A. L. Uss
  • N. F. Milanovich

DOI:

https://doi.org/10.11603/1681-2727.2016.2.6521

Keywords:

haematopoietic stem cell transplantation, febrile neutropenia, risk factors, sepsis biomarkers.

Abstract

Results of original study of risk factors of bacterial infectious complications during haematopoietic stem cell transplantation are presented in this article. Authors have conducted a complex analysis of effectiveness of sepsis biomarkers (procalcitonin, presepsin, C-reactive protein) among haematopoietic stem cell transplant recipients.

References

Gratwohl A. Indications for and current practice of allogeneic and autologous HSCT / A. Gratwohl, H. Baldomero, A. Sureda // The EBMT handbook – haematopoietic stem cell transplantation / [A. Gratwohl, H. Baldomero, A. Sureda]; European Group for Blood and Marrow Transplantation & European School of Hematology. – Paris, 2012. – P. 302-315.

Uss A.L. Vosstanovlenie gemopoe'za posle vy'sokodoznoj khimioterapii s autologichnoj i allogennoj transplantaciej stvolovy'kh gemopoe'ticheskikh kletok / A.L. Uss // Med. panorama. – 2012. – № 3. – P. 48-51.

CIBMTR summary slides − HCT trends and survival data [Electronic resource].–2014. – Mode of access: http://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/ index.aspx. – Data of access: 02.01.2014.

A prospective survey of febrile events in hematological malignancies / [L. Pagano, M. Caira, G. Rossi et al.] // Ann. Hematol. – 2012. – Vol. 91, N 5. – P. 767-774.

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance / [M. Mikulska, V. Del Bono, A.M. Raiola et al.] // Biol. of Blood and Marrow Transplant. – 2009. – Vol. 15, N 1. – P. 47-53.

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients / [B.A. Collin, H.L. Leather, J.R. Wingard et al.] // Clin. Infect. Dis. – 2001. – Vol. 33, N 7. – P. 947-953.

Sickles E.A. Clinical presentation of infection in granulocytopenic patients / E.A. Sickles, W.H. Greene, P.H. Wiernik // Arch. Intern. Med. – 1975. – Vol. 135, N 5. – P. 715-719.

Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures / [O. Penack, P. Remph, M. Eisenblatter et al.] // Ann. Oncol. – 2007. – Vol. 18, N 11. – P. 1870-1874.

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America / [B. Spellberg, R. Guidos, D. Gilbert et al.] // Clin. Infect. Dis. – 2008. – Vol. 46, N 2. – P. 155-164.

Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated / [D. Yokoe, C. Casper, E. Dubberke et al.] // Bone Marrow Transplant. – 2009. – Vol. 44, N 8. – P. 495-507.

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia /

[D. Averbuch, C. Orasch, C. Cordonnier et al.] // Haematologica. – 2013. – Vol. 98, N 12. – P. 1826-1835.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America / [A.G. Freifeld, E.J. Bow, K.A. Sepkowitz et al.] // Clin. Infect. Dis. – 2011. – Vol. 52, N 4. – P. E56-E93.

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective / [M. Tomblyn, T. Chiller, H. Einsele et al.] // Biol. of Blood and Marrow Transplant. – 2009. – Vol. 15, N 10. – P. 1143-1238.

Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections / [E. Velasco, R. Byington, C.A. Martins et al.] // Eur. J. Clin. Microbiol. & Infect. Dis. – 2006. – Vol. 25, N 1. – P. 1-7.

Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients? / [K.S. Massaro, R. Macedo, B.S. de Castro et al.] // Infection. – 2014. – Vol. 42, N 6. – P. 1023-1032.

Published

2016-06-23

How to Cite

Stoma, I. O., Karpov, I. A., Uss, A. L., & Milanovich, N. F. (2016). PROGNOSING BACTERIAL INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HAEMATOPOIETIC STEM CELL TRANSPLANTATION. Infectious Diseases – Infektsiyni Khvoroby, (2), 43–47. https://doi.org/10.11603/1681-2727.2016.2.6521

Issue

Section

Статті